Clearmind Medicine Inc. (CMND)
NASDAQ: CMND · Real-Time Price · USD
1.010
-0.060 (-5.61%)
Oct 21, 2025, 1:45 PM EDT - Market open
Clearmind Medicine Market Cap
Clearmind Medicine has a market cap or net worth of $5.52 million as of October 21, 2025. Its market cap has increased by 9.77% in one year.
Market Cap
5.52M
Enterprise Value
2.38M
1-Year Change
9.77%
Ranking
Category
Stock Price
$1.01
Market Cap Chart
Since August 16, 2021, Clearmind Medicine's market cap has decreased from $26.17M to $5.52M, a decrease of -78.91%. That is a compound annual growth rate of -31.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 20, 2025 | 5.85M | -3.30% |
| Dec 31, 2024 | 6.05M | 27.14% |
| Dec 29, 2023 | 4.76M | -39.13% |
| Dec 30, 2022 | 7.82M | -59.16% |
| Dec 27, 2021 | 19.14M | -26.88% |
| Aug 16, 2021 | 26.17M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 720.73B |
| Johnson & Johnson | 465.34B |
| AbbVie | 405.55B |
| UnitedHealth Group | 322.96B |
| AstraZeneca | 260.83B |
| Novartis AG | 254.64B |
| Novo Nordisk | 237.72B |
| Abbott Laboratories | 223.72B |